Hannah Clarke (@hannahclarke722) 's Twitter Profile
Hannah Clarke

@hannahclarke722

Editor, MJH Life Sciences | MPH candidate at Johns Hopkins University | views expressed are my own

ID: 1618696524891832320

calendar_today26-01-2023 19:45:07

55 Tweet

20 Followers

31 Following

Hannah Clarke (@hannahclarke722) 's Twitter Profile Photo

Another successful #AUA24 in the books! #urology Stay up to date with our ongoing coverage of this year’s meeting here: urologytimes.com/conference/aua.

Another successful #AUA24 in the books! #urology 

Stay up to date with our ongoing coverage of this year’s meeting here: urologytimes.com/conference/aua.
Urology Times (@urologytimes) 's Twitter Profile Photo

Results from an exclusive Urology Times survey reveal that urologists prefer reusable cystoscopes to disposable cystoscopes. #urology #urologist Gopal Badlani urologytimes.com/view/urologist…

Urology Times (@urologytimes) 's Twitter Profile Photo

Join us LIVE on July 17th at 6pm EST as Dr. Ashley Winter MD || Urologist and Dr. Maria Uloko MD discuss the use of vaginal estrogen! Set a reminder and join the event below: x.com/i/spaces/1mrGm…

Hannah Clarke (@hannahclarke722) 's Twitter Profile Photo

The FDA is meeting today to discuss the New Drug Application for oral sulopenem for uncomplicated UTI. Busy day today? No worries — our team is keeping up with the meeting so you don’t have to. Follow along with our real-time updates below. ⬇️

Urology Times (@urologytimes) 's Twitter Profile Photo

Join us LIVE on September 19th at 6pm EST as Dr. Robert Brannigan (Robert E. Brannigan, MD) and Dr. Juan Andino (Juan José Andino) discuss the recent amendment to the male infertility guideline. NM Urology @UCLAUrology   Set a reminder and join the event below! x.com/i/spaces/1ypKd…

Urology Times (@urologytimes) 's Twitter Profile Photo

Data from the phase 3 TiNivo-2 trial showed that the combination of low-dose tivozanib plus nivolumab did not improve PFS, OS, or ORR vs standard-dose tivozanib in patients with advanced renal cell carcinoma. #ESMO24 #kcsm Toni Choueiri, MD Dana-Farber News urologytimes.com/view/ici-combi…

Urology Times (@urologytimes) 's Twitter Profile Photo

Missed our live X Spaces event with Robert E. Brannigan, MD and Juan José Andino on the changes to the male infertility guideline? No worries –– the discussion is now available as a podcast episode on our site! NM Urology UCLA Urology Check out their insights here: urologytimes.com/view/key-updat…

Urology Times (@urologytimes) 's Twitter Profile Photo

Data presented at #PFDWeek24 showed no significant association between the use of vaginal estrogen for genitourinary syndrome of menopause and subsequent major adverse cardiovascular events. University Hospitals Urology Institute #urology urologytimes.com/view/vaginal-e…

Urology Times (@urologytimes) 's Twitter Profile Photo

Dave Winfield (Dave Winfield) delivered a keynote presentation at #LUGPA2024 on lessons learned from baseball and philanthropy. In a podcast episode with Urology Times, he highlights key takeaways from this discussion and more. LUGPA Listen here: urologytimes.com/view/former-ml…

Hannah Clarke (@hannahclarke722) 's Twitter Profile Photo

Today CMSGov announced their selection of the next 15 Medicare Part D drugs to be included in price negotiations under the Inflation Reduction Act. This list includes enzalutamide, which is indicated in the US for patients with prostate cancer. urologytimes.com/view/enzalutam…

Urology Times (@urologytimes) 's Twitter Profile Photo

Adam B. Weiner, MD will be taking over our account on Thursday 2/13 during #GU25. Throughout the day, Dr. Weiner will share his take on key data presented as well as session updates, photos with colleagues, and other notable updates. Stay tuned! Cedars-Sinai + UCLA Urology ASCO

<a href="/Adam_Weiner535/">Adam B. Weiner, MD</a> will be taking over our account on Thursday 2/13 during #GU25. Throughout the day, Dr. Weiner will share his take on key data presented as well as session updates, photos with colleagues, and other notable updates. Stay tuned!
<a href="/CedarsSinai/">Cedars-Sinai</a> + <a href="/UclaUrology/">UCLA Urology</a> <a href="/ASCO/">ASCO</a>
Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

💡Really looking forward to taking over Urology Times to report on some of the biggest works coming out of #GU25 for #prostatecancer 👇Thank you UT & Hannah Clarke for the chance to spot light many great presentations ahead on Thursday ⭐️CAPFISH-3 ⭐️STAMPEDE ⭐️STOPCAT

Johns Hopkins Bloomberg School of Public Health (@johnshopkinssph) 's Twitter Profile Photo

Measles is one of the most contagious infectious diseases. In a susceptible population, one person with measles will infect an average of 12–18 other people. Measles is also vaccine-preventable: Two doses of the MMR vaccine is 97% effective against measles. Get important facts

Dr. Pat Soon-Shiong (@drpatsoonshiong) 's Twitter Profile Photo

A paradigm change in how we approach cancer . Anktiva as a lymphocyte rescue molecule: Unlocking the power of NK cells and T cells urologytimes.com/view/anktiva-a… via @@urologytimes

Urology Times (@urologytimes) 's Twitter Profile Photo

Adam B. Weiner, MD, (Adam B. Weiner, MD) a urologist at Department of Urology at Cedars-Sinai, discusses prostate cancer screening guidelines in light of President Biden's recent diagnosis. urologytimes.com/view/prostate-…

Urology Times (@urologytimes) 's Twitter Profile Photo

EXCLUSIVE 🌟 : The results are in! Our team recently conducted a survey on treatment patterns and preferences in #NMIBC, finding that novel agents in the BCG-unresponsive space face slow uptake. #blcsm Sign up🔓to view the full results: urologytimes.com/view/survey-ne…

EXCLUSIVE 🌟 : The results are in! Our team recently conducted a survey on treatment patterns and preferences in #NMIBC, finding that novel agents in the BCG-unresponsive space face slow uptake. #blcsm 

Sign up🔓to view the full results: urologytimes.com/view/survey-ne…